Monitoring beta-lactam antibiotics in critically ill patients with sepsis
Part of Infections clinical trials.
This study measures levels of beta-lactam antibiotics in the blood of ICU patients with sepsis to ensure the right dose is given. It aims to improve treatment by checking if antibiotic levels are effective without being too high or too low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have sepsis, a serious infection causing organ problems, as defined by a standard score (SOFA at least 2).
- You are starting treatment with a beta-lactam type antibiotic (like penicillin or cephalosporins).
- You or your legal representative can sign a consent form within 48 hours of starting the antibiotic.
- You are not pregnant or breastfeeding.
- You do not have a known allergy to beta-lactam antibiotics.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.
This trial tests whether giving a certain type of antibiotic (beta-lactam) continuously or intermittently works better for patients in the intensive care unit with pneumonia or a urinary tract infection and signs of sepsis. Sepsis is a serious response to an infection, so better antibiotic delivery could improve outcomes.
This study monitors how antibiotics behave in the body for ICU patients being treated for sepsis or septic shock. It aims to learn whether better monitoring can support safer, more effective antibiotic use.
This trial tests a new device that measures antibiotic levels in blood quickly at the bedside, so doctors can adjust your dose to make sure it's effective. It may help ICU patients on beta-lactam antibiotics get the right amount.
This study looks at how well beta-lactam antibiotics (a common type of antibiotic) work in people being treated for infections at Imperial College NHS Trust. The information may help doctors make better dosing decisions.
This trial tests a type of antibiotic called aminoglycosides to treat early sepsis (a serious infection). It is for adults in the hospital who are sick enough to need strong antibiotics but not in the worst stage of the illness.
Hear when a new Bacterial Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.